Trial Profile
Role of Fulvestrant in The Treatment of Metastatic Breast Cancer in Premenopausal Women
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 08 Oct 2021
Price :
$35
*
At a glance
- Drugs Fulvestrant (Primary) ; Goserelin (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 24 Jul 2018 New trial record